NCT03367156View on ClinicalTrials.gov

Dexamethasone in Controlling Dyspnea in Patients With Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

May 5, 2021

Study Completion Date

December 31, 2025

Conditions
DyspneaMalignant Neoplasm
Interventions
DRUG

Dexamethasone

Given PO

OTHER

Placebo

Given PO

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (3)

77026

Lyndon B. Johnson Hospital, Houston

77028

Harris Health System Settegast Health Center, Houston

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER